EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

SUGP2 p.( Arg639Gln ) variant is involved in the pathogenesis of hemochromatosis via the CIRBP / BMPER signaling pathway

Yanmeng Li iD, Anjian Xu iD, Susu Liu, Wei Zhang, Donghu Zhou, Qin OuYang, Huaduan Zi, Bei Zhang, Ning Zhang, Wei Geng, Yiming Zhou, Weijia Duan und 6 weitere

American Journal of Hematology · 2024

DOI: 10.1002/ajh.27377 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Hematology, 2024. Verfasst von Yanmeng Li und 17 weiteren Autor:innen. Beteiligte Einrichtung: Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, …. Hauptthemen laut MEDLINE: Serine-Arginine Splicing Factors, Hemochromatosis, Signal Transduction, RNA-Binding Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Municipal Natural Science Foundation, Digestive Medical Coordinated Development Center of Beijing Municipal Administration of Hospitals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathogenic variants in HFE and non‐ HFE genes have been identified in hemochromatosis in different patient populations, but there are still a certain number of patients with unexplained primary iron overload. We recently identified in Chinese patients a recurrent p.(Arg639Gln) variant in SURP and G‐patch domain containing 2 (SUGP2), a potential mRNA splicing‐related factor. However, the target gene of SUGP2 and affected iron‐regulating pathway remains unknown. We aimed to investigate the pathogenicity and underlying mechanism of this variant in hemochromatosis. RNA‐seq analysis revealed that SUGP2 knockdown caused abnormal alternative splicing of CIRBP pre‐mRNA, resulting in an increased normal splicing form of CIRBP V1, which in turn increased the expression of BMPER by enhancing its mRNA stability and translation. Furthermore, RNA‐protein pull‐down and RNA immunoprecipitation assays revealed that SUGP2 inhibited splicing of CIRBP pre‐mRNA by a splice site variant at CIRBP c.492 and was more susceptible to CIRBP c.492 C/C genotype. Cells transfected with SUGP2 p.(Arg639Gln) vector showed up‐regulation of CIRBP V1 and BMPER expression and down‐regulation of pSMAD1/5 and HAMP expression. CRISPR‐Cas9 mediated SUGP2 p.(Arg622Gln) knock‐in mice showed increased iron accumulation in the liver, higher total serum iron, and decreased serum hepcidin level. A total of 10 of 54 patients with hemochromatosis (18.5%) harbored the SUGP2 p.(Arg639Gln) variant and carried CIRBP c.492 C/C genotype, and had increased BMPER expression in the liver. Altogether, the SUGP2 p.(Arg639Gln) variant down‐regulates hepcidin expression through the SUGP2/CIRBP/BMPER axis, which may represent a novel pathogenic factor for hemochromatosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Serine-Arginine Splicing FactorsHemochromatosisSignal TransductionRNA-Binding ProteinsCarrier ProteinsHumansAnimalsMiceMice, Inbred C57BLCell Line, TumorMice, KnockoutAlternative SplicingIronRNA, MessengerMutation

Substanzen

SUGP2 protein, humanSugp2 protein, mouseSerine-Arginine Splicing FactorsCIRBP protein, humanRNA-Binding ProteinsIronBMPER protein, humanCarrier Proteinscrossveinless 2 protein, mouseCirbp protein, mouse

Autor:innen und Institutionen

  • Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, National Clinical Research Center for Digestive Diseases, Beijing, Chi…
  • Beijing Institute of Clinical Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Division of Animal Model Research, Institute for Laboratory Animal Resources, National Institutes for Food and Drug Control (NIFDC), Beijing, China.
  • Department of Gastroenterology, Beijing United Family Hospital, Beijing, China.
  • Department of Liver Disease, The Seventh Medical Center, Chinese PLA General Hospital, Beijing, China.

ORCID-Profile: Yanmeng Li, Anjian Xu, Jian Huang

Förderung

  • National Natural Science Foundation of China
  • Beijing Municipal Natural Science Foundation
  • Digestive Medical Coordinated Development Center of Beijing Municipal Administration of Hospitals

Zitieren

APA

Li, Y., Xu, A., Liu, S., Zhang, W., Zhou, D., OuYang, Q., Zi, H., Zhang, B., Zhang, N., Geng, W., Zhou, Y., Duan, W., Wang, X., Zhao, X., Ou, X., Fan, C., Jia, J., & Huang, J. (2024). SUGP2 p.( Arg639Gln ) variant is involved in the pathogenesis of hemochromatosis via the CIRBP / BMPER signaling pathway. American Journal of Hematology. https://doi.org/10.1002/ajh.27377

Vancouver

Li Y, Xu A, Liu S, Zhang W, Zhou D, OuYang Q, et al. SUGP2 p.( Arg639Gln ) variant is involved in the pathogenesis of hemochromatosis via the CIRBP / BMPER signaling pathway. American Journal of Hematology. 2024. doi:10.1002/ajh.27377

BibTeX
@article{Li2024,
  author = {Li, Yanmeng and Xu, Anjian and Liu, Susu and Zhang, Wei and Zhou, Donghu and OuYang, Qin and Zi, Huaduan and Zhang, Bei and Zhang, Ning and Geng, Wei and Zhou, Yiming and Duan, Weijia and Wang, Xiaoming and Zhao, Xinyan and Ou, Xiaojuan and Fan, Changfa and Jia, Jidong and Huang, Jian},
  title = {SUGP2 p.( Arg639Gln ) variant is involved in the pathogenesis of hemochromatosis via the CIRBP / BMPER signaling pathway},
  journal = {American Journal of Hematology},
  year = {2024},
  doi = {10.1002/ajh.27377}
}
Kostenlos starten →